novo nordisk glp-1 patent litigation scores court win against copycat compounders Novo Nordisk opens new front

Going direct lets manufacturers own the relationship with the patient

Zepbound is a medication that mimics the effects of GLP-1 (glucagon-like peptide-1), a hormone naturally produced in the body that plays a crucial role in regulating appetite and glucose metabolism

Brain imaging studies have found similar changes in dopamine receptors, the neurotransmitter that creates a feeling of well-being and motivates us to repeat behaviors in people who overeat and use alcohol and drugs

It activates both appetite-regulating pathways for potentially greater weight loss

#Menopause #GLP1 #Perimenopause #WomensHealth A study published in The Lancet Psychiatry in April 2026 tracked nearly 100,000 people with diagnosed depression or anxiety across more than a decade of Swedish national health data

Appetite suppression from GLP-1 or GLP-1/GIP therapy can make this deficiency more likely without intentional meal planning